- Home
- ABVC vs APT Comparison
ABVC vs APT Comparison
Compare ABVC & APT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABVC
- APT
- Stock Information
- Founded
- ABVC 2015
- APT 1983
- Country
- ABVC United States
- APT Canada
- Employees
- ABVC N/A
- APT N/A
- Industry
- ABVC Biotechnology: Pharmaceutical Preparations
- APT
- Sector
- ABVC Health Care
- APT
- Exchange
- ABVC Nasdaq
- APT Nasdaq
- Market Cap
- ABVC 52.1M
- APT 50.5M
- IPO Year
- ABVC N/A
- APT 1995
- Fundamental
- Price
- ABVC $3.30
- APT $4.61
- Analyst Decision
- ABVC
- APT
- Analyst Count
- ABVC 0
- APT 0
- Target Price
- ABVC N/A
- APT N/A
- AVG Volume (30 Days)
- ABVC 223.6K
- APT 21.2K
- Earning Date
- ABVC 08-13-2025
- APT 08-07-2025
- Dividend Yield
- ABVC N/A
- APT N/A
- EPS Growth
- ABVC N/A
- APT N/A
- EPS
- ABVC N/A
- APT 0.33
- Revenue
- ABVC $391,242.00
- APT $58,562,000.00
- Revenue This Year
- ABVC $735.18
- APT N/A
- Revenue Next Year
- ABVC N/A
- APT N/A
- P/E Ratio
- ABVC N/A
- APT $14.03
- Revenue Growth
- ABVC 186.84
- APT N/A
- 52 Week Low
- ABVC $0.40
- APT $4.06
- 52 Week High
- ABVC $5.48
- APT $6.44
- Technical
- Relative Strength Index (RSI)
- ABVC 56.53
- APT 41.28
- Support Level
- ABVC $2.90
- APT $4.62
- Resistance Level
- ABVC $3.06
- APT $4.78
- Average True Range (ATR)
- ABVC 0.28
- APT 0.14
- MACD
- ABVC 0.00
- APT -0.03
- Stochastic Oscillator
- ABVC 91.92
- APT 15.89
About ABVC ABVC BioPharma Inc.
ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. Its drug products focus on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.
About APT Alpha Pro Tech Ltd.
Alpha Pro Tech Ltd is in the business of protecting people, products and environments. It is developing, manufacturing and marketing a line of disposable protective apparel and infection control products for the cleanroom, industrial, pharmaceutical, medical and dental markets. It also manufacture a line of building supply construction weatherization products that are sold under the Alpha Pro Tech brand name. The Company operates through two business segments: Building Supply and Disposable Protective Apparel. Key revenue is generated from Building Supply: consisting of a line of construction supply weatherization products. The construction supply weatherization products consist of housewrap and synthetic roof underlayment and synthetic roof underlayment accessories.